Document:

Exhibit 4.16

 

THIS INDEMNITY is given on the [              ] day of [                            ] Two thousand and Twenty One by NatWest Group plc (“NWG”) which has its registered office situated at 36 St Andrew Square, Edinburgh, EH2 2YB to [Name of Director] (“the Director”).

 

WHEREAS the Director is a duly appointed director or officer of NWG and/or a wholly-owned subsidiary of NWG (collectively, “the NatWest Group”) and may be required, in connection with the business of the NatWest Group and subject to the Director’s consent, to accept office as:

 

(i)           a director or officer of any company within the NatWest Group; and/or

 

(ii)          as appropriate, an authorised or approved person, (or equivalent) under the rules of any regulatory body; and/or

 

(iii)         a director or officer of a company in which a member of the NatWest Group is to invest or has invested in less than 50 per cent of the issued share capital of such company (an “Investee Company”).

 

NOW THIS INDEMNITY WITNESSETH that in consideration of the Director continuing in or accepting (as the case may be) office as a director or officer of any company within the NatWest Group, or as an authorised or approved person (or equivalent), or as a director or officer of an Investee Company as contemplated above, NWG hereby covenants with the Director that NWG will, at all times, hereafter indemnify and keep indemnified the Director, his estate and his personal representatives from all costs, charges, losses, expenses and liabilities incurred by him in the actual or purported execution and/or discharge of his duties and/or the exercise or purported exercise of his powers and/or otherwise in relation to or in connection with his duties, powers or office including (without prejudice to the generality of the foregoing) any liability incurred by him in defending any proceedings, civil or criminal, which relate to anything done or omitted or alleged to have been done or omitted by him as an officer or employee of any company within the NatWest Group (or of an Investee Company) and in which decree or judgement is given in his favour (or the proceedings are otherwise disposed of without any finding or admission of any material breach of duty on his part) or in which he is acquitted or in connection with any application for relief from liability in respect of any such act or omission in which relief is granted to him by the Court.

 

PROVIDED THAT this Indemnity is given subject to the provisions of Section 234 Companies Act 2006.

 

THE DIRECTOR as a condition precedent to his right to be indemnified hereunder, shall, to the full extent permitted by law or other applicable regulatory requirements:

 

(i)           notify NWG in writing, addressed to the Chief Governance Officer and Company Secretary, as soon as reasonably possible after having knowledge or becoming aware, of any such claim made against him or any circumstances which may subsequently give rise to a claim against

 

 

him or lead to an official investigation, examination or other proceedings referred to above;

 

(ii)          keep NWG, through its Chief Governance Officer and Company Secretary and or such individual nominated for that purpose by the Chief Governance Officer and Company Secretary, informed of all matters and supply such information as NWG shall request pertaining to any such claim and any such official investigation, examination or other proceedings referred to above;

 

(iii)         obtain the prior consent of NWG before incurring any costs, charges or expenses in connection with any such claim, admitting any liability for or settling or compromising any such claim, and delegate to NWG the conduct of the defence against any such claim at such time and to such extent as shall be requested by NWG, and further render or cause to be rendered to NWG all such assistance as NWG shall require in connection therewith; and

 

(iv)         use his best endeavours to have recourse to any indemnity or insurance to which he may be entitled before claiming his rights hereunder.

 

IN THE EVENT that the Director shall have incurred any tax liability as a result of any payment hereunder, the amount of such payment to be made by NWG to the Director shall be increased to the extent necessary to ensure that after taking into account such tax liability the Director will receive a net sum equal to the sum he would have received or retained had there been no such tax liability.

 

THIS INDEMNITY shall be construed in accordance with the laws of Scotland and shall extend to claims against the Director enforceable in any other jurisdiction and be fully effectual as and from the [                      ] day of [                            ] Two Thousand and [            ].

 

Signed for and on behalf of NatWest Group plc conform to Commission dated the Thirty first day of December Two Thousand and Twenty and registered in the Books of Council and Session on the [  ] day of [  ] Two Thousand and Twenty One.

 

 

 

 

	
..................................
    	
..................................
    
	
Commissioner and Attorney
    	
[Name of Director]Exhibit 4.3

		

			Exhibit 4.3

		

		

			 

		

		
			DESCRIPTION OF SECURITIES
		

		
			﻿
		

		
			Unless the context otherwise requires, throughout this exhibit, the words “we,” “us,” or “our” refer to Alimera Sciences, Inc. and its subsidiaries (as applicable).
		

		
			﻿
		

		
			Common Stock
		

		
			﻿
		

		
			We currently have authorized 150,000,000 shares of common stock, par value $0.01 per share. As of March 1, 2021, there were 5,753,434 shares of the registrant’s common stock issued and outstanding. Holders of our common stock have no preemptive rights and no right to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock. All outstanding shares of our common stock are fully paid and nonassessable.
		

		
			﻿
		

		
			The following summary of the terms of our common stock is subject to and qualified in its entirety by reference to our restated certificate of incorporation and bylaws, copies of which are on file with the SEC as exhibits to previous SEC filings.
		

		
			﻿
		

		
			Voting Rights. The holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders, including, without limitation, the election of our board of directors. Our stockholders have no right to cumulate their votes in the election of directors.
		

		
			﻿
		

		
			Dividends. Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of our common stock are entitled to receive ratably those dividends declared from time to time by the board of directors.
		

		
			﻿
		

		
			Rights Upon Liquidation. Subject to preferences that may apply to shares of preferred stock outstanding at the time, in the event of liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in assets remaining after payment of liabilities.
		

		
			﻿
		

		
			Anti-Takeover Effects of Our Restated Certificate of Incorporation, Bylaws and Delaware Law. Some provisions of Delaware law and our restated certificate of incorporation and bylaws could make the following transactions more difficult: our acquisition by means of a tender offer; our acquisition by means of a proxy contest or otherwise; or removal of our incumbent officers and directors.
		

		
			﻿
		

		
			Section 203 of the Delaware General Corporation Law is applicable to takeovers of Delaware corporations. Subject to exceptions enumerated in Section 203, Section 203 provides that a corporation shall not engage in any business combination with any “interested stockholder” for a three-year period following the date that the stockholder becomes an interested stockholder unless:
		

		
			﻿
		

			
	
			
				 ·
			

			
	
			
			prior to that date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;

			
	
			
				 ·
			

			
	
			
			upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, though some shares may be excluded from the calculation; and

			
	
			
				 ·
			

			
	
			
			on or subsequent to that date, the business combination is approved by the board of directors of the corporation and by the affirmative votes of holders of at least two-thirds of the outstanding voting stock that is not owned by the interested stockholder.

		
			﻿
		

		
			Except as specified in Section 203, an interested stockholder is generally defined to include any person who, together with any affiliates or associates of that person, beneficially owns, directly or indirectly, 15% or more of the outstanding voting stock of the corporation, or is an affiliate or associate of the corporation and was the owner of 15% or more of the outstanding voting stock of the corporation, any time within three years immediately prior to the relevant date. Under certain circumstances, Section 203 makes it more difficult for an interested stockholder to effect various business combinations with a corporation for a three-year period, although the stockholders may elect not to be governed by this section, by adopting an amendment to the certificate of incorporation or bylaws, effective 12 months after adoption. Our restated certificate of incorporation and bylaws do not opt out from the restrictions imposed under Section 203. We anticipate that the provisions of Section 203 may encourage companies interested in acquiring us to negotiate in advance with the board because the stockholder approval requirement would be avoided if a majority of the directors then in office excluding an interested stockholder approve either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder. These provisions may have the effect of deterring hostile takeovers or delaying changes in control, which could depress the market price of our common stock and deprive stockholders of opportunities to realize a premium on shares of common stock held by them.
		

		
			﻿
		

		
			In addition to our board of directors’ ability to issue shares of preferred stock, our restated certificate of incorporation and bylaws contain provisions that may discourage, delay or prevent a change in our management or control over us that stockholders may consider favorable. Our restated certificate of incorporation and bylaws:
		

		

		

		 

		

			1

		

		

			 

		

 

		﻿
		

			
	
			
				 ·
			

			
	
			
			authorize the issuance of “blank check” preferred stock that could be issued by our board of directors to thwart a takeover attempt;

			
	
			
				 ·
			

			
	
			
			do not provide for cumulative voting in the election of directors, which would allow holders of less than a majority of the stock to elect some directors;

			
	
			
				 ·
			

			
	
			
			establish a classified board of directors, as a result of which the successors to the directors whose terms have expired will be elected to serve from the time of election and qualification until the third annual meeting following their election;

			
	
			
				 ·
			

			
	
			
			require that directors only be removed from office for cause;

			
	
			
				 ·
			

			
	
			
			provide that vacancies on the board of directors, including newly-created directorships, may be filled only by a majority vote of directors then in office;

			
	
			
				 ·
			

			
	
			
			limit who may call special meetings of stockholders;

			
	
			
				 ·
			

			
	
			
			prohibit stockholder action by written consent, requiring all actions to be taken at a meeting of the stockholders; and

			
	
			
				 ·
			

			
	
			
			establish advance notice requirements for nominating candidates for election to the board of directors or for proposing matters that can be acted upon by stockholders at stockholder meetings.

		
			﻿
		

		
			Transfer Agent and Registrar. The transfer agent and registrar for our common stock is American Stock Transfer & Trust Company LLC.
		

		
			﻿
		

		
			Listing. Our common stock is listed on The Nasdaq Global Market under the symbol “ALIM.”

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}]]